Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenhoff

Showing results (361-370 of 398) with videos related to

Pageof 40
Sort By:
Bone Marrow Transplantation|August 18, 2020
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q DeletionLaurent Garderet, Dimitris Ziagkos, Anja van Biezen, et al.
Haematologica|February 9, 2018
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMTNico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Hemasphere|February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working PartyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Blood|April 26, 2013
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trialUlf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, et al.
Bone Marrow Transplantation|January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMTJuan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Pageof 40

Showing results (361-370 of 398) with videos related to

Sort By:
Pageof 40
Bone Marrow Transplantation|August 18, 2020
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q DeletionLaurent Garderet, Dimitris Ziagkos, Anja van Biezen, et al.
Haematologica|February 9, 2018
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMTNico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Hemasphere|February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working PartyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Blood|April 26, 2013
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trialUlf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, et al.
Bone Marrow Transplantation|January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMTJuan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Pageof 40